Penserra Capital Management’s Prime Medicine PRME Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,468	Closed	-$176K	–	1329
2023 Q3	$176K	Buy	18,468 +10,361	+128%	+$98.7K	﹤0.01%	776
2023 Q2	$118K	Buy	8,107 +1,107	+16%	+$16.1K	﹤0.01%	911
2023 Q1	$86K	Sell	7,000 -570	-8%	-$7K	﹤0.01%	792
2022 Q4	$140K	Buy	+7,570	New	+$140K	﹤0.01%	755